151 



Victor J, DeNnblc. Ph.D. 

 1200 Camp Woods Court 

 Newark. Delaware 1 97 11 

 June 30, 1994 



Mr. Thomas J. Bliley, Jr. 

 U.S. House of Representatives 

 2241 Rayburn Office Building 

 Washington, DC 20515-4607 



Dear Congressman Bliley: 



Thank you for your letter dated June 1 3, 1 994 asking me to respond 

 to additional questions concerning the issue of tobacco and health. In 

 answering your questions, I am compelled to tell you that I am somewhat 

 confused as to the nature and intent of the questions you have forwarded 

 The questions have no relevance to tobacco and health and represent an 

 inquiry into my employment history before and after Philip Morris. When I 

 was requested to appear before the congressional subcommittee on April 28, 

 1 994, 1 did so voluntarily and discussed research projects that were 

 performed by me and my colleagues for Philip Morris, Inc. between April 1. 

 1980 and April 5. 1984. Since the nicotine research has been replicated in 

 laboratories all over the world over the last ten years, there can be no 

 question regarding the validity of the research. With regard to the 

 acetaldehyde data, I understand that Philip Morris has graciously submitted 

 the raw data, as well as. reports to the subcommittee and I encourage the 

 subcommittee to conduct an independent scientific review of my conclusion 

 that acetaldehyde is a reinforcing agent. I am disappointed that the 

 questions provided to me deal exclusively with my work history and do not 

 relate in any way to the information provided to the subcommittee. I 

 question whether other individuals who voluntarily give testimony to the 

 subcommittee are subject to a persona! review because their testimony may 

 not suit selected members of that subcommittee. As you will see, my 

 responses to your questions have no bearing on either my testimony given 

 10 the subcommittee, on the research performed at Philip Morris 



